Grants and Contributions:

Title:
Doctoral Research Award - Priority Announcement - HIV/AIDS and/or STBBI
Agreement Number:
183723
Agreement Value:
$120,000.00
Agreement Date:
Sep 1, 2025 - Aug 31, 2028
Description:
• The CIHR HIV/AIDS and STBBI Research Initiative (RI), under the leadership of the CIHR Institute of Infection and Immunity (III), is responsible for the funding, management and oversight of research with a primary focus on HIV/AIDS and/or other STBBI. This includes, but is not limited to: human immunodeficiency virus (HIV), hepatitis B (HBV) and C (HCV), chlamydia, gonorrhea, syphilis, and human papilloma virus (HPV). This funding is provided across all CIHR Research Themes: biomedical research, clinical research, health services research and social, cultural, environmental and population health research. • Research that focuses on key populations and strategic directions identified in the CIHR HIV/AIDS Research Initiative: Strategic Plan (2015-2020) is highly encouraged.
Organization:
Canadian Institutes of Health Research
Expected Results:

This program provides funding for targeted grants and awards aimed at addressing priority areas. Priorities are identified by CIHR in consultation with other government departments and agencies, partners and stakeholders. The program mobilizes researchers, patients, health providers, and decision makers to conduct research, enable knowledge translation and build capacity in the priority areas. It often requires collaboration within and across sectors.

Location:
Toronto, Ontario, CA H3C 3J7
Reference Number:
236-2025-2026-Q2-00635
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient Type:
Individual or sole proprietorship
Recipient's Legal Name:
Selim, Alaa S
Research Organization:
University of Toronto
Program:
Research in Priority Areas
Program Purpose:

This program provides funding for targeted grants and awards aimed at addressing priority areas. Priorities are identified by CIHR in consultation with other government departments and agencies, partners and stakeholders. The program mobilizes researchers, patients, health providers, and decision makers to conduct research, enable knowledge translation and build capacity in the priority areas. It often requires collaboration within and across sectors.